La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Lepu Medical Technology (Beijing) Crescita futura

Future criteri di controllo 4/6

Lepu Medical Technology (Beijing) prevede che gli utili e i ricavi cresceranno rispettivamente di 25.7% e 15.3% all'anno. Si prevede che l'EPS crescerà di 25.6% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 11.8% in 3 anni.

Informazioni chiave

25.7%

Tasso di crescita degli utili

25.6%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	22.6%
Tasso di crescita dei ricavi	15.3%
Rendimento futuro del capitale proprio	11.8%
Copertura analitica	Good
Ultimo aggiornamento	20 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28

Previsioni di crescita degli utili e dei ricavi

SZSE:300003 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	11,558	2,664	N/A	3,247	7
12/31/2025	10,153	2,300	N/A	2,716	8
12/31/2024	8,893	1,991	N/A	2,767	8
3/31/2024	7,465	1,143	488	1,266	N/A
12/31/2023	7,980	1,258	146	990	N/A
9/30/2023	9,107	1,746	642	1,573	N/A
6/30/2023	9,577	1,896	794	1,754	N/A
3/31/2023	10,498	2,254	1,320	2,208	N/A
12/31/2022	10,609	2,204	1,885	2,791	N/A
9/30/2022	9,787	1,608	1,611	2,558	N/A
6/30/2022	9,473	1,262	1,118	2,106	N/A
3/31/2022	10,460	1,539	1,211	2,212	N/A
1/1/2022	10,660	1,719	2,078	3,062	N/A
9/30/2021	10,286	1,750	1,954	2,812	N/A
6/30/2021	10,321	2,387	2,269	3,086	N/A
3/31/2021	9,121	2,144	2,567	3,284	N/A
12/31/2020	8,039	1,802	1,490	2,090	N/A
9/30/2020	8,303	2,086	1,700	2,312	N/A
6/30/2020	8,112	1,710	1,899	2,424	N/A
3/31/2020	7,584	1,526	1,294	1,839	N/A
12/31/2019	7,796	1,725	1,427	1,990	N/A
9/30/2019	7,652	1,687	1,152	1,834	N/A
6/30/2019	7,323	1,564	998	1,669	N/A
3/31/2019	6,799	1,498	877	1,557	N/A
12/31/2018	6,356	1,219	429	1,501	N/A
9/30/2018	5,832	1,304	361	1,241	N/A
6/30/2018	5,310	1,214	206	1,063	N/A
3/31/2018	4,942	970	189	954	N/A
12/31/2017	4,538	899	N/A	913	N/A
9/30/2017	4,234	874	N/A	772	N/A
6/30/2017	3,974	797	N/A	728	N/A
3/31/2017	3,701	734	N/A	770	N/A
12/31/2016	3,468	679	N/A	692	N/A
9/30/2016	3,318	649	N/A	778	N/A
6/30/2016	3,113	610	N/A	693	N/A
3/31/2016	2,938	569	N/A	509	N/A
12/31/2015	2,769	521	N/A	436	N/A
9/30/2015	2,419	520	N/A	374	N/A
6/30/2015	2,208	500	N/A	363	N/A
3/31/2015	1,934	458	N/A	324	N/A
12/31/2014	1,669	423	N/A	348	N/A
9/30/2014	1,578	405	N/A	277	N/A
6/30/2014	1,490	385	N/A	284	N/A
3/31/2014	1,375	362	N/A	330	N/A
12/31/2013	1,303	362	N/A	330	N/A
9/30/2013	1,215	353	N/A	295	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 300003 ( 25.7% all'anno) è superiore al tasso di risparmio ( 2.9% ).

Guadagni vs Mercato: Si prevede che gli utili di 300003 ( 25.7% all'anno) cresceranno più rapidamente del mercato CN ( 21.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 300003 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di 300003 ( 15.3% all'anno) crescerà più rapidamente del mercato CN ( 13.4% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 300003 ( 15.3% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 300003 sarà basso tra 3 anni ( 11.8 %).

Lepu Medical Technology (Beijing) Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus revenue estimates fall by 17%

Price target decreased by 11% to CN¥20.69

Price target decreased by 10% to CN¥24.02

Price target decreased by 8.6% to CN¥28.09

Consensus revenue estimates fall by 11%

Price target increased to CN¥31.40

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing) Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Dividend reduced to CN¥0.33

Lepu Medical Technology (Beijing) Co., Ltd. Implements 2023 Final Profit Distribution for A Shares, Payable on 27 June 2024

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Consensus revenue estimates fall by 17%

Price target decreased by 11% to CN¥20.69

Lepu Medical Technology (Beijing) Co., Ltd., Annual General Meeting, May 15, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Investor sentiment improves as stock rises 15%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024

Price target decreased by 10% to CN¥24.02

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Price target decreased by 8.6% to CN¥28.09

Consensus revenue estimates fall by 11%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution for 2022, Payable on 30 June 2023

Lepu Medical Technology (Beijing) Co., Ltd. Approves the Election of Wang Qihong as Non-Independent Director and Qu Xin as Independent Director

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Price target increased to CN¥31.40

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Lepu Medical Technology (Beijing) Co., Ltd. has completed a Follow-on Equity Offering in the amount of $224.238141 million.

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution on Share A for 2021, Payable on June 30, 2022

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2021

Price target decreased to CN¥29.12

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Dividend for 2021

First quarter 2022 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Price target decreased to CN¥35.05

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.43 in 2Q 2020)

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2020

First quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.22 in 1Q 2020)

Consensus EPS estimates fall to CN¥1.24

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Cash Dividend for the Year 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.07 (vs CN¥0.97 in FY 2019)

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment improved over the past week

New 90-day high: CN¥32.23

New 90-day low: CN¥27.72

New 90-day low: CN¥29.09

Price target lowered to CN¥37.44

Third quarter earnings released

New 90-day low: CN¥31.28

New 90-day low - CN¥34.56

First half earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita